(Q35065238)

6 August 2017

1 reference

title

Sleep disturbances in Parkinson's disease. (English)

1 reference

6 August 2017

1 reference

Cynthia L Comella

1

1 reference

6 August 2017

1 March 2003

1 reference

Current Neurology and Neuroscience Reports

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

2

1 reference

6 August 2017

173-180

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-003-0073-2

6 August 2017

0 references

cites work

Sleep disturbances in Parkinson's disease patients and spouses.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Parkinson's disease and sleepiness: an integral part of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

A polysomnographic and clinical report on sleep-related injury in 100 adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

REM sleep behavior disorders in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Magnetic resonance findings in REM sleep behavior disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Treatment of REM sleep behavior disorder with donepezil: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Daytime sleepiness and other sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Development of daytime somnolence over time in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0073-2

Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness

21 January 2018

1 reference

12 December 2020

Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.

1 reference

12 December 2020

Paradoxical sleep and its chemical/structural substrates in the brain

1 reference

12 December 2020

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

12 December 2020

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

12 December 2020

Effect of L-dopa on the sleep of man.

1 reference

12 December 2020

Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.

1 reference

12 December 2020

REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

1 reference

12 December 2020

REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography?

1 reference

12 December 2020

Different behaviors during paradoxical sleep without atonia depend on pontine lesion site.

1 reference

12 December 2020

Respiration and Heart Rate Variability during Sleep in Untreated Parkinson Patients

1 reference

12 December 2020

Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.

1 reference

12 December 2020

The parkinsonian tremor in sleep

1 reference

12 December 2020

The Association of Age and Depression Among the Elderly: An Epidemiologic Exploration

1 reference

12 December 2020

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

1 reference

12 December 2020

A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group

1 reference

12 December 2020

Sleep disorders and depression in patients with Parkinson's disease.

1 reference

12 December 2020

The nighttime problems of Parkinson's disease.

1 reference

12 December 2020

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.

1 reference

12 December 2020

Ropinirole for restless legs syndrome

1 reference

12 December 2020

Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group

1 reference

12 December 2020

Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease

1 reference

12 December 2020

Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease.

1 reference

12 December 2020

REM inhibitory effect of L-DOPA infusion during human sleep

1 reference

12 December 2020

FAST TRACK: daytime sleepiness in Parkinson's disease.

1 reference

12 December 2020

Respiration and sleep in Parkinson's disease

1 reference

12 December 2020

Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study

1 reference

12 December 2020

Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings

1 reference

12 December 2020

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

12 December 2020

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

1 reference

12 December 2020

Sleep studies. Current techniques and future trends

1 reference

12 December 2020

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.

1 reference

12 December 2020

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745

1 reference

12 December 2020

A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy

1 reference

12 December 2020

1 reference

12 December 2020

A community-based study of sleep disorders in patients with Parkinson's disease.

1 reference

12 December 2020

Chronic behavioral disorders of human REM sleep: a new category of parasomnia

1 reference

12 December 2020

Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy

1 reference

12 December 2020

Sleep disorders and sleep effect in Parkinson's disease.

1 reference

12 December 2020

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

1 reference

12 December 2020

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

12 December 2020

Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration

1 reference

12 December 2020

Efficacy of quetiapine in Parkinson's patients with psychosis

1 reference

12 December 2020

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

12 December 2020

Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy.

1 reference

12 December 2020

10.1007/S11910-003-0073-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12583848